VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS THEREOF

Provided is a compound selected from compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof: (I) wherein R1, R2, R3 and R4 are as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HETTINGER, Donald, HARRIOTT, Nicole, CULHANE, Jeffrey, C, BRANUM, Shawn
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HETTINGER, Donald
HARRIOTT, Nicole
CULHANE, Jeffrey, C
BRANUM, Shawn
description Provided is a compound selected from compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof: (I) wherein R1, R2, R3 and R4 are as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, neurological and psychiatric diseases and disorders. Also disclosed are compositions containing such compounds in combination with a pharmaceutically acceptable carrier, as well as methods relating to their use in subjects in need thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3612532A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3612532A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3612532A13</originalsourceid><addsrcrecordid>eNrjZDAK83UMMVLw9PPwdPIM8Q9ScPb3DfAP9XMJVnD0c4Hwgj1DPP39ghVCPFyDXP3deBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAsZmhkamxkaOhMRFKAERGJp4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS THEREOF</title><source>esp@cenet</source><creator>HETTINGER, Donald ; HARRIOTT, Nicole ; CULHANE, Jeffrey, C ; BRANUM, Shawn</creator><creatorcontrib>HETTINGER, Donald ; HARRIOTT, Nicole ; CULHANE, Jeffrey, C ; BRANUM, Shawn</creatorcontrib><description>Provided is a compound selected from compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof: (I) wherein R1, R2, R3 and R4 are as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, neurological and psychiatric diseases and disorders. Also disclosed are compositions containing such compounds in combination with a pharmaceutically acceptable carrier, as well as methods relating to their use in subjects in need thereof.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200226&amp;DB=EPODOC&amp;CC=EP&amp;NR=3612532A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200226&amp;DB=EPODOC&amp;CC=EP&amp;NR=3612532A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HETTINGER, Donald</creatorcontrib><creatorcontrib>HARRIOTT, Nicole</creatorcontrib><creatorcontrib>CULHANE, Jeffrey, C</creatorcontrib><creatorcontrib>BRANUM, Shawn</creatorcontrib><title>VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS THEREOF</title><description>Provided is a compound selected from compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof: (I) wherein R1, R2, R3 and R4 are as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, neurological and psychiatric diseases and disorders. Also disclosed are compositions containing such compounds in combination with a pharmaceutically acceptable carrier, as well as methods relating to their use in subjects in need thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAK83UMMVLw9PPwdPIM8Q9ScPb3DfAP9XMJVnD0c4Hwgj1DPP39ghVCPFyDXP3deBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAsZmhkamxkaOhMRFKAERGJp4</recordid><startdate>20200226</startdate><enddate>20200226</enddate><creator>HETTINGER, Donald</creator><creator>HARRIOTT, Nicole</creator><creator>CULHANE, Jeffrey, C</creator><creator>BRANUM, Shawn</creator><scope>EVB</scope></search><sort><creationdate>20200226</creationdate><title>VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS THEREOF</title><author>HETTINGER, Donald ; HARRIOTT, Nicole ; CULHANE, Jeffrey, C ; BRANUM, Shawn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3612532A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HETTINGER, Donald</creatorcontrib><creatorcontrib>HARRIOTT, Nicole</creatorcontrib><creatorcontrib>CULHANE, Jeffrey, C</creatorcontrib><creatorcontrib>BRANUM, Shawn</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HETTINGER, Donald</au><au>HARRIOTT, Nicole</au><au>CULHANE, Jeffrey, C</au><au>BRANUM, Shawn</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS THEREOF</title><date>2020-02-26</date><risdate>2020</risdate><abstract>Provided is a compound selected from compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof: (I) wherein R1, R2, R3 and R4 are as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, neurological and psychiatric diseases and disorders. Also disclosed are compositions containing such compounds in combination with a pharmaceutically acceptable carrier, as well as methods relating to their use in subjects in need thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3612532A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T08%3A10%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HETTINGER,%20Donald&rft.date=2020-02-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3612532A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true